These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 1489095)
1. Quantitative immunoassay of human deoxycytidine kinase in malignant cells. Kawasaki H; Carrera CJ; Carson DA Anal Biochem; 1992 Nov; 207(1):193-6. PubMed ID: 1489095 [TBL] [Abstract][Full Text] [Related]
2. Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues. Spasokoukotskaja T; Arnér ES; Brosjö O; Gunvén P; Juliusson G; Liliemark J; Eriksson S Eur J Cancer; 1995; 31A(2):202-8. PubMed ID: 7718326 [TBL] [Abstract][Full Text] [Related]
3. Properties and levels of deoxynucleoside kinases in normal and tumor cells; implications for chemotherapy. Eriksson S; Arnér E; Spasokoukotskaja T; Wang L; Karlsson A; Brosjö O; Gunvén P; Julusson G; Liliemark J Adv Enzyme Regul; 1994; 34():13-25. PubMed ID: 7942271 [TBL] [Abstract][Full Text] [Related]
4. Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Kawasaki H; Carrera CJ; Piro LD; Saven A; Kipps TJ; Carson DA Blood; 1993 Feb; 81(3):597-601. PubMed ID: 8094016 [TBL] [Abstract][Full Text] [Related]
6. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity. Kim W; Le TM; Wei L; Poddar S; Bazzy J; Wang X; Uong NT; Abt ER; Capri JR; Austin WR; Van Valkenburgh JS; Steele D; Gipson RM; Slavik R; Cabebe AE; Taechariyakul T; Yaghoubi SS; Lee JT; Sadeghi S; Lavie A; Faull KF; Witte ON; Donahue TR; Phelps ME; Herschman HR; Herrmann K; Czernin J; Radu CG Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4027-32. PubMed ID: 27035974 [TBL] [Abstract][Full Text] [Related]
7. Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes. Nielsen SE; Munch-Petersen B; Mejer J Leuk Res; 1995 Jul; 19(7):443-7. PubMed ID: 7637389 [TBL] [Abstract][Full Text] [Related]
8. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells. Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121 [TBL] [Abstract][Full Text] [Related]
9. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia. Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271 [TBL] [Abstract][Full Text] [Related]
10. Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes. Van Den Neste E; Smal C; Cardoen S; Delacauw A; Frankard J; Ferrant A; Van den Berghe G; Bontemps F Biochem Pharmacol; 2003 Feb; 65(4):573-80. PubMed ID: 12566084 [TBL] [Abstract][Full Text] [Related]
11. Positive regulation of deoxycytidine kinase activity by phosphorylation of Ser-74 in B-cell chronic lymphocytic leukaemia lymphocytes. Smal C; Van Den Neste E; Maerevoet M; Poiré X; Théate I; Bontemps F Cancer Lett; 2007 Aug; 253(1):68-73. PubMed ID: 17350163 [TBL] [Abstract][Full Text] [Related]
12. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Arnér ES; Spasokoukotskaja T; Eriksson S Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886 [TBL] [Abstract][Full Text] [Related]
13. Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver. van der Wilt CL; Kroep JR; Loves WJ; Rots MG; Van Groeningen CJ; Kaspers GJ; Peters GJ Eur J Cancer; 2003 Mar; 39(5):691-7. PubMed ID: 12628850 [TBL] [Abstract][Full Text] [Related]
14. Deoxycytidine kinase and deoxycytidine deaminase activities in human tumour xenografts. Ruiz van Haperen VW; Veerman G; Braakhuis BJ; Vermorken JB; Boven E; Leyva A; Peters GJ Eur J Cancer; 1993; 29A(15):2132-7. PubMed ID: 8297652 [TBL] [Abstract][Full Text] [Related]
15. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation]. Staub M Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873 [TBL] [Abstract][Full Text] [Related]
16. Activation of deoxycytidine kinase during inhibition of DNA synthesis in human lymphocytes. Sasvári-Székely M; Csapó Z; Spasokoukotskaja T; Eriksson S; Staub M Adv Exp Med Biol; 1998; 431():519-23. PubMed ID: 9598121 [TBL] [Abstract][Full Text] [Related]
17. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity. Hapke DM; Stegmann AP; Mitchell BS Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309 [TBL] [Abstract][Full Text] [Related]
18. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine. Kong XB; Tong WP; Chou TC Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001 [TBL] [Abstract][Full Text] [Related]
19. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes. Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase. Someya H; Shaddix SC; Tiwari KN; Secrist JA; Parker WB J Pharmacol Exp Ther; 2003 Mar; 304(3):1314-22. PubMed ID: 12604712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]